Health Catalyst, Inc. (HCAT) Net margin 2017–2025
Health Catalyst, Inc. (HCAT) net profit margin by fiscal year — reported net income divided by reported revenue.
-57.2%FY2025 · since FY2017: -64.4% → -57.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -57.2% | -34.5 pp |
| FY2024 | -22.7% | +17.3 pp |
| FY2023 | -39.9% | +9.8 pp |
| FY2022 | -49.7% | +13.6 pp |
| FY2021 | -63.3% | -2.4 pp |
| FY2020 | -60.9% | -22.1 pp |
| FY2019 | -38.8% | +16.3 pp |
| FY2018 | -55.1% | +9.3 pp |
| FY2017 | -64.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More HCAT financial trends
HCAT RevenueHCAT Net incomeHCAT Gross profitHCAT Gross marginHCAT Operating incomeHCAT Operating marginHCAT Operating cash flowHCAT Free cash flowHCAT Capital expendituresHCAT Return on equityHCAT Stock buybacksHCAT Dividends paidHCAT Total assetsHCAT Total liabilitiesHCAT Shareholders’ equityHCAT overview →